Paragon 28, Inc. (FNA) News

Paragon 28, Inc. (FNA): $5.74

0.03 (+0.53%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Filter FNA News Items

FNA News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest FNA News From Around the Web

Below are the latest news stories about PARAGON 28 INC that investors may wish to consider to help them evaluate FNA as an investment opportunity.

Paragon 28 (FNA) BEAST Cortical Fibers Launch Boosts Biologics

Paragon 28's (FNA) BEAST Cortical Fibers' advanced processing capability ensures the preservation of native bone morphogenic proteins and other growth factors crucial for bone formation.

Yahoo | November 20, 2023

Paragon 28 (FNA) New Staple System Expands Ankle Device Line

Paragon 28's (FNA) JAWS Great White Staple System is claimed to have 400 times greater fatigue life compared to competitors under similar load conditions.

Yahoo | November 16, 2023

Paragon 28 Launches BEAST™ Cortical Fibers Expanding its Biologics Portfolio

ENGLEWOOD, Colo., November 14, 2023--Paragon 28, Inc. (NYSE: FNA) is pleased to announce the launch of its BEAST™ Cortical Fibers which provide an osteoinductive porous structure for cellular attachment and an osteoinductive potential to aid in cellular differentiation and bone formation. These loose cortical fibers are engineered to complement specific surgical applications in the foot and ankle and are flexible upon hydration allowing for application even in extremely challenging fusion locati

Yahoo | November 14, 2023

Paragon 28 Launches JAWS™ Great White Staple System Further Expanding its Nitinol Staple Offering

ENGLEWOOD, Colo., November 14, 2023--Paragon 28, Inc. (NYSE: FNA) is pleased to announce the launch of its JAWS™ Great White Staple System which was developed to provide for increased strength and stability of the osteotomy or fusion site when compared to traditional staple systems. The staples feature an ultra-low-profile bridge with increased surface area to enhance stability while minimizing soft tissue irritation. The newly designed staple has 400 times the fatigue life compared to a competi

Yahoo | November 14, 2023

Paragon 28 Adds Second Mobile Medical Education Lab Significantly Expanding Upon Wildly Successful Foot and Ankle Surgeon Training Program

ENGLEWOOD, Colo., November 13, 2023--Paragon 28, Inc. (NYSE: FNA) is pleased to announce the addition of a second trailer to its nationwide mobile lab training program making it even more convenient for the company to facilitate on-site surgeon training and education. Paragon 28’s new mobile lab is housed in a 40 foot tractor-trailer which includes a state-of-the-art, 5 station, cadaveric training facility accommodating up to 25 surgeons. The mobile lab will host over 70 training sessions in app

Yahoo | November 13, 2023

Paragon 28, Inc. (NYSE:FNA) Q3 2023 Earnings Call Transcript

Paragon 28, Inc. (NYSE:FNA) Q3 2023 Earnings Call Transcript November 11, 2023 Operator: Good afternoon. And welcome to Paragon 28’s Third Quarter 2023 Earnings Conference Call. Currently, participants are in listen-only mode. We will be facilitating a question-and-answer session at the end of today’s call. As a reminder, this call is being recorded for replay […]

Yahoo | November 12, 2023

Market Participants Recognise Paragon 28, Inc.'s (NYSE:FNA) Revenues

Paragon 28, Inc.'s ( NYSE:FNA ) price-to-sales (or "P/S") ratio of 3.8x may not look like an appealing investment...

Yahoo | November 9, 2023

Q3 2023 Paragon 28 Inc Earnings Call

Q3 2023 Paragon 28 Inc Earnings Call

Yahoo | November 8, 2023

Paragon 28 Reports Third Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance

ENGLEWOOD, Colo., November 07, 2023--Paragon 28, Inc. (NYSE: FNA) ("Paragon 28" or "Company"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today reported financial results for the quarter ended September 30, 2023 and reaffirmed its 2023 net revenue guidance.

Yahoo | November 7, 2023

Paragon 28 Announces New $150 Million Credit Facility Replacing Existing $90 Million Credit Facility

ENGLEWOOD, Colo., November 07, 2023--Paragon 28, Inc. (NYSE: FNA) ("Paragon 28" or "Company"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that it has received a new $150 million credit facility from Ares Capital Corporation ("the Facility") to replace its existing $90 million senior credit facility. The Facility is comprised of up to $100 million in term loans, with $75 million drawn at close, and a $50 million revolving credit f

Yahoo | November 7, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!